|
2023
|
Invention
|
Oromucosal delivery system containing remimazolam. The present invention relates to oromucosal de... |
|
|
Invention
|
Dosing regimen for sedation with cns 7056 (remimazolam). The invention relates to a dosing regime... |
|
2022
|
Invention
|
Orally inhaled and nasal benzodiazepines.
The present invention relates to Orally Inhaled and Na... |
|
2021
|
Invention
|
Compositions comprising short-acting benzodiazepines.
The present invention provides novel compo... |
|
|
G/S
|
Sedatives, anaesthetics, hypnotics, anxiolytics, muscle
relaxants, anticonvulsants and analgesics. |
|
|
Invention
|
Short-acting benzodiazepine salts and their polymorphic forms.
The invention relates to besylate... |
|
2020
|
Invention
|
Dosing regimen for sedation with cns 7056 (remimazolam).
The invention relates to a dosing regim... |
|
|
G/S
|
Sedatives, general anaesthetics, anaesthetics for surgical use, hypnotics, anxiolytics, muscle re... |
|
|
Invention
|
Medical uses for benzodiazepines with a particular eeg pattern. The present invention relates to ... |
|
2019
|
Invention
|
Short-acting benzodiazepine salts and their polymorphic forms. The invention relates to besylate ... |
|
2018
|
Invention
|
Process for preparing 3-[(s)-7-bromo-2-((2-oxopropyl)amino)-5-pyridin-2-yl-3h-1,4-benzodiazepin-3... |
|
2017
|
Invention
|
Orally inhaled and nasal benzodiazepines. The present invention relates to Orally Inhaled and Nas... |
|
|
Invention
|
Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepi... |
|
2015
|
G/S
|
Sedatives, anaesthetics, hypnotics, anxiolytics, muscle relaxants, anticonvulsants and analgesics... |
|
|
Invention
|
Process for preparing 3-[(45)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepi... |
|
2014
|
Invention
|
Injectable composition for general anesthesia and/or sedation. An injectable composition which co... |
|
|
Invention
|
Oxidation reaction excellent in conversion rate. A method of producing, at a high conversion rate... |
|
|
Invention
|
Oxidation reaction with excellent conversion rate. A method of producing, at a high conversion ra... |
|
2013
|
Invention
|
Dosing regimen of sedative.
By intravenously administering a sedative comprising methyl 3-[(4S)-... |
|
|
Invention
|
Method for administering hypnotic/sedative agent. A hypnotic/sedative agent comprising methyl 3-[... |
|
|
Invention
|
Dosing regimen of sedative. A hypnotic/sedative agent comprising methyl 3-[(4S)-8-bromo-1-methyl-... |
|
|
Invention
|
Compositions comprising short-acting benzodiazepines.
A composition is provided with a benzodiaz... |
|
|
Invention
|
Compositions comprising short-acting benzodiazepines. A composition is provided with a benzodiaze... |
|
2010
|
Invention
|
Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazep... |
|
2008
|
Invention
|
Administration scheme of polar opioid metabolites for post-operative pain management.
Administra... |
|
|
Invention
|
Administration scheme of polar opioid metabolites for post-operative pain management. Administrat... |
|
2007
|
Invention
|
Short-acting benzodiazepine salts and their polymorphic forms. The invention relates to esylate s... |
|
|
Invention
|
Short-acting benzodiazepines. The present invention provides a compound of formula (I):
wherein... |
|
|
Invention
|
Short-acting benzodiazepines. It has now been found that compounds of the present invention as de... |
